Maximum quantity allowed is 999
CAS RN: 1744-22-5 | Product Number: A2423
Riluzole

Purity: >98.0%(T)(HPLC)
- 2-Amino-6-(trifluoromethoxy)benzothiazole
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
5G |
₹6,900.00
|
5 | 1 |
|
25G |
₹13,600.00
|
3 | 22 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | A2423 |
Purity / Analysis Method ![]() |
>98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__8H__5F__3N__2OS = 234.20 |
Physical State (20 deg.C) | Solid |
Storage Temperature ![]() |
Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 1744-22-5 |
Reaxys Registry Number | 748759 |
PubChem Substance ID | 253662378 |
Merck Index (14) | 8223 |
MDL Number | MFCD00210213 |
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
Melting point | 116.0 to 120.0 °C |
NMR | confirm to structure |
Melting Point | 118 °C |
Solubility in water | Insoluble |
Solubility (soluble in) | Acetone, Dimethylformamide, Ether, Methanol |
Pictogram |
![]() |
Signal Word | Danger |
Hazard Statements | H300 : Fatal if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
RTECS# | DL2830000 |
UN Number | UN2811 |
Class | 6.1 |
Packing Group | II |
References
- The pharmacology and mechanism of action of riluzole
- Riluzole: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis
- Riluzole Series. Synthesis and in Vivo "Antiglutamate" Activity of 6-Substituted-2-benzothiazolamines and 3-Substituted-2-imino-benzothiazolines
- Riluzole, neuroprotection and amyotrophic lateral sclerosis (a review)
- A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? (a review)
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.